Market Overview:
The global perphenazine market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing demand for injectable perphenazine solutions, and growing awareness about mental health disorders. However, the high cost of treatment and lack of skilled professionals are some factors that are restraining the growth of this market. The global perphenazine market is segmented on the basis of type, application, and region. On the basis of type, it is divided into oral forms and injectable solution. Oral forms are further classified into tablets and capsules while injectable solution is further classified into ampoules and vials. On the basis of application, it is segmented into psychosis and antiemetic. Region-wise, it is analyzed across North America (U S Canada), Latin America (Mexico Brazil), Europe (Germany France Italy Spain U K Rest Of Europe), Asia Pacific (Japan China India Australia South Korea Rest Of Asia Pacific) And Middle East & Africa(GCC Countries Turkey Nigeria South Africa Rest Of MEA).
Product Definition:
A phenothiazine antipsychotic agent used in the treatment of schizophrenia.
Oral Forms:
Oral forms are the solid or liquid medications that are taken in the mouth. They can be administered to patients in various ways such as tablets, capsules, syrups and solutions. The most commonly used oral form of phenobarbital is Sancilio (Phenobar) which is a chewable tablet containing Phenobarbital sodium.
The global market for oral forms of Perphenazine was valued at USD 536 million in 2016.
Injectable Solution:
Injectable solution is a form of drug delivery system that allows drugs to be administered by the intravenous or subcutaneous route. The injectable solution market is expected to witness lucrative growth over the forecast period owing to increasing demand for long-acting formulations and growing incidence of diseases such as diabetes, which require chronic treatment.
Injectables are used in treating various disorders such as arthritis, asthma, osteoporosis and obesity among others.
Application Insights:
The global perphenazine market is segmented based on application into psychosis, antiemetic and others. The other applications include analgesia, sedation and general anesthesia. In 2017, the antiemetic segment dominated the overall market with a share of over 60% in terms of revenue as well as volume. This high share was primarily due to extensive usage for emetophobia (an abnormal fear of vomiting) and nausea associated with cancer chemotherapy or radiotherapy treatment.
Perphenazine is used for treating various conditions such as Parkinson¢â‚¬â„¢s disease; anxiety disorders; attention deficit hyperactivity disorder (ADHD); epilepsy; multiple sclerosis; rheumatoid arthritis & osteoarthritis pain management etc., which are majorly prevalent in developing countries including India, China Japan Brazil etc., Hence increasing demand from these regions may lead to an increase in perphenazine consumption globally during the forecast period.
Regional Analysis:
North America dominated the global perphenazine market in 2017. The high prevalence of mental disorders and increasing awareness about available treatment options are some of the major factors contributing to its growth. In addition, presence of key manufacturers such as Cipla Inc.; FMC Corporation; Sun Pharmaceutical Industries Ltd.; and Shire US LLC is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising disposable income, improving healthcare infrastructure, growing patient awareness levels coupled with increasing government initiatives for tackling substance abuse problems especially in developing countries such as India.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. This is expected to drive the demand for perphenazine in the coming years.
- Growing awareness about mental health: There is a growing awareness about the importance of mental health and its impact on overall well-being. This is likely to increase the demand for perphenazine in the coming years.
- Rising incidence of stress and anxiety: The incidence of stress and anxiety is rising at an alarming rate, leading to an increased need for treatment options such as perphenazine.
- Growing number of research studies on perphenazine: There has been a significant increase in research studies on perphenazine in recent years, indicating its potential therapeutic benefits over other medications used for treating mental disorders.. This is likely to fuel the growth of the market in future.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Perphenazine Market Research Report
By Type
Oral Forms, Injectable Solution
By Application
Psychosis, Antiemetic
By Companies
Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Perphenazine Market Report Segments:
The global Perphenazine market is segmented on the basis of:
Types
Oral Forms, Injectable Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Psychosis, Antiemetic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Sandoz
- Endo
- Mylan
- ZHPHARMA
- Shandong Boshan Pharma
Highlights of The Perphenazine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Forms
- Injectable Solution
- By Application:
- Psychosis
- Antiemetic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Perphenazine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Perphenazine is an antipsychotic medication. It works by blocking the receptors in the brain that are responsible for sending signals that cause symptoms of schizophrenia.
Some of the key players operating in the perphenazine market are Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma.
The perphenazine market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Perphenazine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Perphenazine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Perphenazine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Perphenazine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Perphenazine Market Size & Forecast, 2020-2028
4.5.1 Perphenazine Market Size and Y-o-Y Growth
4.5.2 Perphenazine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Forms
5.2.2 Injectable Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Psychosis
6.2.2 Antiemetic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Perphenazine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Perphenazine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Forms
9.6.2 Injectable Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Psychosis
9.10.2 Antiemetic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Forms
10.6.2 Injectable Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Psychosis
10.10.2 Antiemetic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Forms
11.6.2 Injectable Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Psychosis
11.10.2 Antiemetic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Forms
12.6.2 Injectable Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Psychosis
12.10.2 Antiemetic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Forms
13.6.2 Injectable Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Psychosis
13.10.2 Antiemetic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Perphenazine Market: Competitive Dashboard
14.2 Global Perphenazine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Sandoz
14.3.3 Endo
14.3.4 Mylan
14.3.5 ZHPHARMA
14.3.6 Shandong Boshan Pharma
